Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies

Article Properties
Cite
Octavia, Yanti, et al. “Doxorubicin-Induced Cardiomyopathy: From Molecular Mechanisms to Therapeutic Strategies”. Journal of Molecular and Cellular Cardiology, vol. 52, no. 6, 2012, pp. 1213-25, https://doi.org/10.1016/j.yjmcc.2012.03.006.
Octavia, Y., Tocchetti, C. G., Gabrielson, K. L., Janssens, S., Crijns, H. J., & Moens, A. L. (2012). Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies. Journal of Molecular and Cellular Cardiology, 52(6), 1213-1225. https://doi.org/10.1016/j.yjmcc.2012.03.006
Octavia Y, Tocchetti CG, Gabrielson KL, Janssens S, Crijns HJ, Moens AL. Doxorubicin-induced cardiomyopathy: From molecular mechanisms to therapeutic strategies. Journal of Molecular and Cellular Cardiology. 2012;52(6):1213-25.
Journal Categories
Medicine
Internal medicine
Specialties of internal medicine
Diseases of the blood and blood-forming organs
Medicine
Internal medicine
Specialties of internal medicine
Diseases of the circulatory (Cardiovascular) system
Science
Biology (General)
Cytology
Science
Biology (General)
Genetics
Refrences
Refrences Analysis
The category Medicine: Internal medicine: Specialties of internal medicine: Diseases of the circulatory (Cardiovascular) system 124 is the most frequently represented among the references in this article. It primarily includes studies from Circulation The chart below illustrates the number of referenced publications per year.
Refrences used by this article by year
Citations
Citations Analysis
The first research to cite this article was titled Highly Synergistic Effect of Sequential Treatment with Epigenetic and Anticancer Drugs To Overcome Drug Resistance in Breast Cancer Cells Is Mediated via Activation of p21 Gene Expression Leading to G2/M Cycle Arrest and was published in 2012. The most recent citation comes from a 2024 study titled Highly Synergistic Effect of Sequential Treatment with Epigenetic and Anticancer Drugs To Overcome Drug Resistance in Breast Cancer Cells Is Mediated via Activation of p21 Gene Expression Leading to G2/M Cycle Arrest . This article reached its peak citation in 2021 , with 113 citations.It has been cited in 426 different journals, 24% of which are open access. Among related journals, the Scientific Reports cited this research the most, with 22 citations. The chart below illustrates the annual citation trends for this article.
Citations used this article by year